Bertil Lindmark is Chief Medical Officer of Galecto, Inc.. Currently has a direct ownership of 16,604 shares of GLTO, which is worth approximately $8,468. The most recent transaction as insider was on Mar 22, 2022, when has been sold 14,604 shares (Common Stock) at a price of $2.16 per share, resulting in proceeds of $31,545. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.6K
0% 3M change
0% 12M change
Total Value Held $8,468

Bertil Lindmark Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 22 2022
BUY
Open market or private purchase
$31,545 $2.16 p/Share
14,604 Added 46.8%
16,604 Common Stock
Jun 28 2021
BUY
Open market or private purchase
$10,520 $5.26 p/Share
2,000 Added 50.0%
2,000 Common Stock
BL

Bertil Lindmark

Chief Medical Officer
Copenhagen N, G7

Track Institutional and Insider Activities on GLTO

Follow Galecto, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLTO shares.

Notify only if

Insider Trading

Get notified when an Galecto, Inc. insider buys or sells GLTO shares.

Notify only if

News

Receive news related to Galecto, Inc.

Track Activities on GLTO